BBNX

Beta Bionics, Inc.

$15.8

-2.09

(-11.68%)

Exchange:	NASDAQ
Market Cap:	685.029M
Shares Outstanding:

Overview

Earnings

Financials

Valuation

Chart

About The Company

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.

Click to read more…

Revenue Segmentation

Error loading revenue segmentation data: No data found for the specified symbol.

Error loading geo segmentation data: No data found for the specified symbol.

EPS

View full analyst estimates

Earnings Call

No transcript or summary available for this symbol.

Income Statement

Balance Sheet

Cash Flow Statement

Analyst Estimates

Income Statement

(* All numbers are in thousands)

No data found.


? Revenue
? Cost Of Revenue
? Gross Profit
? Research And Development Expenses
? General And Administrative Expenses
? Selling And Marketing Expenses
? Operating Expenses
? Net Interest Income
? Interest Income
? Interest Expense
? Depreciation And Amortization
? EBITDA
? EBIT
? Operating Income
? Income Before Tax
? Income Tax Expense
? Net Income From Continuing Operations
? Net Income
? EPS (Earnings Per Share)
? EPS Diluted
? Weighted Average Shares Outstanding
? Weighted Average Shares Outstanding Diluted

Balance Sheet

(* All numbers are in thousands)

No data found.


? Cash And Cash Equivalents
? Short Term Investments
? Cash And Short Term Investments
? Net Receivables
? Accounts Receivables
? Inventory
? Total Current Assets
? Property Plant Equipment Net
? Goodwill
? Intangible Assets
? Long Term Investments
? Total Non Current Assets
? Total Assets
? Account Payables
? Short Term Debt
? Deferred Revenue
? Total Current Liabilities
? Long Term Debt
? Deferred Revenue Non Current
? Deferred Tax Liabilities Non Current
? Total Non Current Liabilities
? Total Liabilities
? Treasury Stock
? Preferred Stock
? Common Stock
? Retained Earnings
? Additional Paid In Capital
? Total Stockholders Equity
? Total Equity
? Minority Interest
? Total Liabilities And Total Equity
? Total Investments
? Total Debt
? Net Debt

Cash Flow Statement

(* All numbers are in thousands)

No data found.


? Net Income
? Depreciation And Amortization
? Deferred Income Tax
? Stock Based Compensation
? Change In Working Capital
? Accounts Receivables
? Inventory
? Accounts Payables
? Net Cash Provided By Operating Activities
? Investments In Property Plant And Equipment
? Acquisitions Net
? Purchases Of Investments
? Sales Maturities Of Investments
? Net Cash Provided By Investing Activities
? Net Debt Issuance
? Long Term Net Debt Issuance
? Short Term Net Debt Issuance
? Net Stock Issuance
? Net Dividends Paid
? Common Dividends Paid
? Preferred Dividends Paid
? Net Cash Provided By Financing Activities
? Effect Of Forex Changes On Cash
? Net Change In Cash
? Cash At End Of Period
? Cash At Beginning Of Period
? Operating Cash Flow
? Capital Expenditure
? Free Cash Flow

Analyst Estimates

(* All numbers are in thousands)

Fiscal Year
Estimated Revenue (Low)
Estimated Revenue (High)
Estimated Revenue (Avg)
Estimated Ebitda (Low)
Estimated Ebitda (High)
Estimated Ebitda (Avg)
Estimated Net Income (Low)
Estimated Net Income (High)
Estimated Net Income (Avg)
Estimated SGA Expense (Low)
Estimated SGA Expense (High)
Estimated SGA Expense (Avg)
Estimated EPS (Avg)
Estimated EPS (High)
Estimated EPS (Low)
Number of Analysts (Estimated Revenue)
Number of Analysts (Estimated EPS)

Subscribe

Log in

Current Key Metrics

?	Revenue (TTM) :	65.124M	?	P/S (TTM) :	11.45
?	Net Income (TTM) :	-54756000	?	P/E (TTM) :	-7.97
?	Enterprise Value (TTM) :	740.164M	?	EV/FCF (TTM) :	-15.52
?	Dividend Yield (TTM) :	0	?	Payout Ratio (TTM) :	0
?	ROE (TTM) :	-0.57	?	ROIC (TTM) :	-0.16
?	Net Debt (TTM) :	-96320000	?	Debt/Equity (TTM) :	0.02
?	P/B (TTM) :	1.75	?	Current Ratio (TTM) :	15.88

Forward P/E Ratios

?

Forward P/E calculated based on:

Forward P/E 1Y	Forward P/E 2Y	Forward P/E 3Y	Forward P/E 4Y	Forward P/E 5Y
N/A	N/A	N/A	N/A	N/A

SWOT Analysis

No SWOT analysis available for this stock.

BBNX

-11.68

-13.85

9.49

4.64

-33.14

Trading Metrics:

Open:	18.31	Previous Close:	17.89
Day Low:	15.76	Day High:	18.34
Year Low:	8.89	Year High:	24.5
Price Avg 50:	14.45	Price Avg 200:	16.02
Volume:	370191	Average Volume:	511037

BBNX

Beta Bionics, Inc.

About The Company

Revenue Segmentation

EPS

Earnings Call

Income Statement

Balance Sheet

Cash Flow Statement

Analyst Estimates

Current Key Metrics

Forward P/E Ratios

SWOT Analysis

Relevant news

Leave a Reply Cancel reply